C4 Imaging

C4 Imaging Develops Innovative Medical Devices Enabling Clinicians to Deliver Personalized Treatment to Patients Through Precise Image-Guided Procedures. The Company’s Core Proprietary Technology, C4, is a Unique Magnetic Resonance Imaging (MRI) Agent Encapsulated Within an Implantable, Biocompatible Shell. C4 Imaging's First Product is the Sirius™ MRI Marker, Which Will Be Used to Facilitate Seed Localization During Prostate Cancer Treatment. The Sirius™ MRI Marker Will Allow Physicians to Accurately Localize Seeds Within the Complex Anatomy of the Prostate and Surrounding Critical Structures Using a Single Post-Implant MR Imaging Procedure. C4 Imaging Aims to Enhance Quality Assurance by Enabling Post-Implant Seed Localization Using Only MRI, Eliminating the Need for Computed Tomography When Evaluating Prostate Brachytherapy.